Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
22.15
+0.11 (0.48%)
At close: Apr 17, 2025, 4:00 PM
22.24
+0.09 (0.43%)
After-hours: Apr 17, 2025, 7:45 PM EDT
Pfizer Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Pfizer stock have an average target of 30.86, with a low estimate of 24 and a high estimate of 45. The average target predicts an increase of 39.35% from the current stock price of 22.15.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Pfizer stock from 15 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 7 | 8 | 8 | 8 | 8 | 9 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 14 | 14 | 14 | 14 | 15 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| UBS | UBS | Hold Maintains $28 → $24 | Hold | Maintains | $28 → $24 | +8.38% | Apr 8, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy → Hold Downgrades $32 → $25 | Strong Buy → Hold | Downgrades | $32 → $25 | +12.89% | Apr 8, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 18, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates n/a | Strong Buy | Reiterates | n/a | n/a | Mar 12, 2025 |
| Guggenheim | Guggenheim | Strong Buy Reiterates $33 | Strong Buy | Reiterates | $33 | +49.02% | Feb 10, 2025 |
Financial Forecast
Revenue This Year
63.66B
from 63.63B
Increased by 0.05%
Revenue Next Year
63.57B
from 63.66B
Decreased by -0.14%
EPS This Year
2.99
from 1.41
Increased by 111.63%
EPS Next Year
3.08
from 2.99
Increased by 3.15%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 67.8B | 70.1B | 70.3B | ||
| Avg | 63.7B | 63.6B | 62.5B | ||
| Low | 60.1B | 59.1B | 57.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 6.6% | 10.1% | 10.7% | ||
| Avg | 0.1% | -0.1% | -1.7% | ||
| Low | -5.5% | -7.2% | -10.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.27 | 3.40 | 3.57 | ||
| Avg | 2.99 | 3.08 | 3.07 | ||
| Low | 2.80 | 2.58 | 2.53 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 131.3% | 13.9% | 15.8% | ||
| Avg | 111.6% | 3.1% | -0.5% | ||
| Low | 98.6% | -13.8% | -18.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.